The prospect of hemoglobin-based blood substitutes: Still a long stony road to go.

[1]  H. Redl,et al.  Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock* , 2005, Critical care medicine.

[2]  T. Wada,et al.  Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase‐1 in an anchorage‐dependent cell ECV304 , 2004, Journal of cellular biochemistry.

[3]  A. Greenburg,et al.  Hemoglobin-based oxygen carriers , 2004, Critical care.

[4]  E. Moore,et al.  The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. , 2002, Journal of the American College of Surgeons.

[5]  Irwin Gratz,et al.  Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. , 2002, The Journal of thoracic and cardiovascular surgery.

[6]  R. Winslow.  αα–Crosslinked Hemoglobin: Was Failure Predicted by Preclinical Testing? , 2000, Vox Sanguinis.

[7]  D. Gens,et al.  Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic Shock: A Randomized Controlled Efficacy Trial , 1999 .

[8]  M. Kaste,et al.  Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. , 1999, Stroke.

[9]  J. Eaton.  Hemoglobin-based blood substitutes: a dream-like trade of blood and guile? , 1996, The Journal of laboratory and clinical medicine.

[10]  A. Choi,et al.  Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. , 1995, American journal of respiratory cell and molecular biology.